1 Min Read
Feb 8 (Reuters) - Sanofi Sa
* CEO says has made no provisions regarding class action launched in France over anti-epilepsy drug Depakine
* CEO says believes group has fulfilled information obligations on Depakine Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.